Bradford, Daniel W. (1999). “Atypical anti psychotic drugs in treatment refractory schizophrenia”. Psychiatric Annals.
Goldman-Rakic PS (1999) The physiological approach: Functional architecture of working memory and disordered cognition in schizophrenia. Biol Psychiatry 46: 650–661. 8. Durham J (2009). Schizophrenia: A review of pharmacologic and nonpharmacologic treatments.
Works Cited 1. Nancy C. Andreasen, (1985), Positive vs. Negative Schizophrenia: A Critical Evaluation, Schizophrenia Bulletin, 11, 380-389 2. Juan R. Bustillo, MD et al, (2001), The Psychosocial Treatment of Schizophrenia, American Journal of Psychiatry, 158, 163-175. 3.
Lack of insight refers to an unawareness of having a disorder, unawareness of having psychotic symptoms, and a refusal of treatment. Some scientists include other more specific aspects such as patients' views on cause of their disorder and/or symptoms, hospitalization, control of situation, or perception of the environment. Only the three aspects listed previously, though, seem common to all definitions of what lack of insight encompasses. Lack of insight has been associated with schizophrenia for a while, with all studies on the subject reaching at least this minimal conclusion. However, there have been some differing conclusions on what causes lack of insight in schizophrenia.
(1998) Cognitive therapy for paranoid schizophrenics: Applying cognitive dissonance, Journal of Cognitive Psychotherapy: An International Quarterly, 12, (1), 3-12. 8) Morrison, A. P., Wells, A. & Nothard, S. (2000) Cognitive factors in predisposition to auditory and visual hallucinations, British Journal of Clinical Psychology, 39, 67-78. 9) Patterson, T. (1987). 'Studies toward the subcortical pathogenesis of schizophrenia', Schizophrenia.
(2002). Psychological treatments in schizophrenia: I. Meta-analysis of family interventions and cognitive behaviour therapy. Psychological Medicine, 32, 763–782. Sensky T., Turkington D., Kingdon D., Scott J. L., Scott J., Siddle R., O'Carroll M. & Barnes T. (2000). A randomised controlled trial of cognitive-behavioural therapy for persistent symptoms in schizophrenia resistant to medication.
Mental illness ranges anywhere from extremely mild cases to some of the more severe illness such as schizophrenia (Brown, Kaylene; Bradley, Loretta J. 2002). Schizophrenia is a mental illness, which affects one percent of the American population. It is a severe mental illness that affects the brain. For many people schizophrenia is debilitating it is known to prevent an individual from being able to have a normal life (Koch, J.
Hamilton, M. Fish?s Clinical Psvchopathology, ed. 2, Wright, Bristol, 1985. Henn, F. A., Naerallah, H. A,, editors: Schizophrenia as a Brain Disease. Oxford, New York, 1982. Naerallah, H. A., Weinberger, D. R. The Neurology of Schizophrenia, In Handbook of Schizophrenia, H. A. Nasrallah, editor, Vol.
Retrieved from http://www.nimh.nih.gov/health/publications/schizophrenia/how-is-schizophrenia-treated.shtml Preston, J. D., O'Neal, J. H., & Talaga, M. C. (2010). Handbook of clinical psychopharmacology for therapists. (Sixth ed., pp. 1-360). Oakland, CA: New Harbinger Publications, Inc. Spearing, M. K. (2002).
Relationship between auditory processing and affective prosody in schizophrenia. Schizophrenia Research, 143(2/3), 348-353 Kaprinis, S. (2008). Auditory processing in schizophrenia. Annals Of General Psychiatry, 71. McLachlan, N. M., Phillips, D. S., Rossell, S. L., & Wilson, S. J.